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The general effects of cocaine are not well understood at the molecular level. What is known is that the dopamine D1 receptor plays an
important role. Here we show that a key mechanism may be cocaine’s blockade of the histamine H3 receptor-mediated inhibition of D1
receptor function. This blockade requires the1 receptor andoccurs upon cocaine binding to1-D1-H3 receptor complexes. The cocaine-
mediated disruption leaves an uninhibited D1 receptor that activates Gs , freely recruits -arrestin, increases p-ERK 1/2 levels, and
induces cell death when over activated. Using in vitro assays with transfected cells and in ex vivo experiments using both rats acutely
treated or self-administeredwith cocaine alongwithmice depleted of1 receptor, we show that blockade of1 receptor by an antagonist
restores the protective H3 receptor-mediated brake on D1 receptor signaling and prevents the cell death from elevated D1 receptor
signaling. These findings suggest that a combination therapy of 1R antagonists with H3 receptor agonists could serve to reduce some
effects of cocaine.
Introduction
The striatum is involved in the learning and elicitation of reward-
related behaviors. GABAergic striatal medium sized spiny neu-
rons (MSNs) comprise95% of striatal neurons and receive two
main extrinsic inputs, cortical-limbic-thalamic glutamatergic
and mesencephalic dopaminergic, converging in the dendritic
spines of the MSNs (Ferre´ et al., 2007). There are two distinct
MSNs, giving rise to two efferent pathways of the basal ganglia,
the striatonigral MSN or direct pathway and the striatopallidal
MSN or the indirect pathway. These neurons selectively express
dopamine D1 (D1R) and D2 (D2R) receptors, respectively. The
initiation of movement leads to dual input of these two pathways
(Cui et al., 2013). Despite the dual input, it is the balance of both
types of MSNs that determines the final striatal output and the
facilitation and inhibition of specificmotor responses involved in
reward-related behavior (Gerfen and Surmeier, 2011). Drugs of
abuse are able to subvert these balanced inputs by altering the cell
signaling of striatopallidal and striatonigral MSN. In the case of
cocaine, it binds to and inhibits the dopamine transporter (DAT)
producing a large increase in extracellular dopamine (Williams
and Galli, 2006). This is associated with an increase in D1R sig-
naling while D2R density is decreased, tipping the balance of
signaling toward the direct pathway (Pascoli et al., 2012; Volkow
et al., 2013). Our work suggests that the role of D1R in cocaine’s
effects depends on the ability of 1 receptors (1R) to bind and
differentially modulate D1R and D2R in both MSNs (Navarro et
al., 2010, 2013). Cocaine, especially in the form of crack, is asso-
ciated with toxic consequences such as seizures and death. The
biochemical alterations that follow the intake of cocaine are not
well understood, but several studies indicate that D1R is involved
in cocaine’s effects (Ritz and George, 1997; Aksenov et al., 2006;
Lepsch et al., 2009).
In addition to glutamatergic and dopaminergic inputs, the
striatum receives hypothalamic histaminergic input, which re-
leases histamine from asynaptic varicosities (Takagi et al., 1986).
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Histamine H3 receptors (H3R) are highly expressed presynapti-
cally and postsynaptically in the striatal spine module (Ellen-
broek, 2013; Panula and Nuutinen, 2013) and mostly localized
postsynaptically in both types ofMSNwhere they can control the
D1R signaling through the formation of D1R-H3R receptor het-
eromers (Moreno et al., 2011a; Ellenbroek, 2013; Panula and
Nuutinen, 2013). This heteromer acts as a relay where activated
H3R can serve as a “molecular brake” for D1R signaling. This
effect is reached through amolecular protein-protein interaction
between receptors in the heteromer. This is a common biochem-
ical property of receptor heteromers, and it is defined as an inter-
molecular interaction by which the presence of one receptor, or
the ligand binding to one receptor unit in the heteromer, changes
positively or negatively the binding and/or the functional prop-
erties of another receptor unit in the heteromer (Ferre´ et al.,
2009). These interprotomer interactions or cross-talk have been
described for D1R-H3R heteromers upon heteromer coactivation
with agonists(Ferrada et al., 2009). Thus, through a negative
cross-talk between receptors, H3R agonist decreases the D1R ag-
onist affinity and signaling. Some receptor heteromers, including
D1R-H3R heteromers, have been found to display cross-
antagonism, the ability of an antagonist of one receptor to also
antagonize the signaling of the partner receptor (Ferrada et al.,
2009; Moreno et al., 2011b; Gonza´lez et al., 2012). Cross-
antagonism requires heteromer formation for any cross-receptor
effects as antagonists do not signal on their own. Thus, cross-
antagonism can be used as a fingerprint for identification of the
presence of the heteromer (Ferre´ et al., 2009). In this frame here
we explore a new physiological role for D1R-H3R heteromers
with the idea of using theH3R-mediated inhibitory effects of D1R
signaling to dampen cocaine’s effects. We found that H3R activa-
tion blocks D1R agonist-mediated cell death in striatal organo-
typic cultures. We discovered a potentially key biochemical
mechanism involved in the effects of cocaine. Cocaine strongly
disrupts D1R-H3R heteromer function, including the neuropro-
tective effects of H3R activation in the D1R-H3R heteromer. We
thus propose the association of 1R antagonists with H3 receptor
agonists as a therapeutic approach for cocaine abuse.
Materials andMethods
Animals, cocaine acute treatment, and cocaine self-administration. All an-
imal protocols were in accordance with the European Communities
Council Directive 86/609/EEC and approved by the Ethics Committee
for Human and Animal Research of the Universitat Auto`noma de Bar-
celona. A maximal effort was made to minimize the number and suffer-
ing of animals.Male SpragueDawley rats were obtained from the Animal
Service, Universitat Auto`nomade Barcelona, Bellaterra, Spain. To obtain
rats self-administered with cocaine, our protocol exhaustively described
previously (Hoffmann et al., 2012) was used. To obtain rats acutely
treatedwith cocaine, rats (6–11weeks old) were conditioned to handling
during previous days to a single 15 mg/kg cocaine intraperitoneal injec-
tion (free base) dissolved in saline. As naive rats, 9- to 11-week-old rats
(350 g) were housed in a temperature (21  1°C) and humidity-
controlled (55 10%) room with a 12 h light/dark cycle with food and
waterad libitum. In all cases, 4%isoflurane (2-chloro-2- (difluoromethoxy)-
1,1,1-trifluoro-ethane) anesthetized animals were killed by decapitation
to obtain rat brains. Brains from wild-type (WT) littermates and 1R
knock-out (KO) CD1 albino Swiss male mice (8 weeks old, 25 g) were
generously provided by Laboratorios Esteve (Barcelona, Spain). The
characterization of these mice has been previously described (Langa et
al., 2003). Cocaine-HCl was purchased from Spanish Agencia del Medi-
camento #2003C00220.
Striatal slices preparation. Mouse or rat brains were rapidly removed
and placed in ice-cold oxygenated (O2/CO2: 95%/5%)Krebs-HCO3
 buf-
fer (124 mM NaCl, 4 mM KCl, 1.25 mM KH2PO4, 1.5 mM MgCl2, 1.5 mM
CaCl2, 10 mM glucose and 26 mM NaHCO3, pH 7.4). The brains were
sliced perpendicularly to the long axis of the striatum at 4°C using a brain
matrix (Zivic Instruments). Slices (500 m thick) were kept at 4°C in
Krebs-HCO3
 buffer during the dissection. Each striatal slice was trans-
ferred into an incubation tube containing 1 ml of ice-cold Krebs-HCO3

buffer. The temperature was raised to 23°C and after 30 min, the media
was replaced by 2ml of fresh Krebs-HCO3
 buffer (23°C). The slices were
incubated under constant oxygenation (O2/CO2: 95%/5%) at 30°C for
4–5 h in an Eppendorf Thermomixer (5 Prime). Themedia was replaced
by 200 l of fresh Krebs-HCO3
 buffer and incubated for 30 min before
the addition of any agent. Slices were treated or not with the indicated
ligand for the indicated time. After the indicated incubation period, the
solution was discarded, and slices were frozen on dry ice and stored at
80°C.
Organotypic striatal slice cultures and cell death determination.Coronal
striatal slices (500 m thickness) from 7- to 8-week-old rats were ob-
tained using a brain matrix and cultured in Neurobasal medium supple-
mented with 20% horse serum, 0.5% B27, 2 mM L-glutamine, 100 g/ml
sodium pyruvate, MEM Non-Essential Amino Acids Solution (1/100),
and 100 U/ml penicillin/streptomycin (all supplements were from Invit-
rogen). After 24 h, culture medium was replaced by fresh medium con-
taining no ligands or the indicated concentrations of the 1R ligands
cocaine or PRE-084. After 1 h, medium, SCH 23390, imetit, or thiopera-
mide were added at the indicated concentrations and incubated for an
additional 1 h before the addition of D1R agonist. Slices weremaintained
48 h more in culture. When the 1R antagonist PD 144418 was used it
was added 1 h before the addition of cocaine. After the total 72 h of
culture, 10M propidium iodide (PI) was added andmaintained at 37°C
for 1 h, then slices were washed twice in cold-PBS and fixed with 4%
paraformaldehyde for 1 h at 4°C. Slices were stained withHoechst 1:1000
and total and PI-positive nuclei were quantified using Leica SP2 confocal
microscope (20; UV, 561 lasers) and the quantification program
Image-based Tool for Counting Nuclei for ImageJ.
Cell culture, expression vectors, and transient transfection.Human neu-
roblastoma SK-N-MC cell clone expressing human D1R and H3R was
developed and grown as previously described (Ferrada et al., 2009) Hu-
man embryonic kidney (HEK293T) cells were grown in DMEM supple-
mented with 2 mM L-glutamine, 100 g/ml sodium pyruvate, 100 U/ml
penicillin/streptomycin, MEM Non-Essential Amino Acids Solution (1/
100), and 5% (v/v) heat-inactivated fetal bovine serum. For transfection,
sequences encoding fusion proteins H3R-Rluc, D1R-Rluc, 1R-YFP,
H3R-YFP, D1R-YFP, and 1R-GFP
2, which correspond with the human
receptors fused to Renilla luciferase (Rluc) or to fluorescent proteins YFP
or GFP2 on the C-terminal end of the receptor, were obtained and char-
acterized as previously described (Ferrada et al., 2009; Navarro et al.,
2010, 2013). Cells were transiently transfected with the corresponding
fusion protein cDNA by the ramified polyethylenimine (PEI; Sigma)
method (Ferrada et al., 2009; Navarro et al., 2010, 2013) or by the lipo-
fectamine (Invitrogen) method, in transfections where siRNA was pres-
ent, following the instructions of the supplier. siRNA that targets both
human and rodent 1R RNA and a scrambled control siRNA were
purchased from Invitrogen (catalog #HSS 145543). To control the cell
number, sample protein concentration was determined using a Brad-
ford assay kit (Bio-Rad) using bovine serum albumin (BSA) dilutions
as standards.
Lentivirus production and cell transduction. Silencing lentiviral vectors
were produced by cotransfecting HEK293 cells with lentiviral silencing
plasmids GIPZ Human SIGMAR1 shRNA (Clone Id:V3LHS_377499 or
V3LHS_406026; Thermo Scientific) with packing plasmid psPAX2 and
envelope coding plasmid pMD2.G (Addgene #12260 and #12259, respec-
tively) using the calcium phosphate method. For production of control
nonsilencing lentiviral particles the 1R silencing plasmids were substi-
tuted with GIPZ Non-silencing Lentiviral shRNA Control (RHS4346;
Thermo Scientific). Infectious lentiviral particles were harvested at 48 h
post-transfection, centrifuged 10min at 3000 rpm to get rid of cell debris,
and then filtered through 0.45 m cellulose acetate filters. The titer of
recombinant lentivirus was determined by serial dilution on HEK293T
cells. For lentivirus transduction, SK-N-MC cells were subcultured to
50% confluence, cells were transduced with 1R-shRNA-expressing len-
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tivirus obtained with plasmid V3LHS_377499 (LV sh) or control-
shRNA-expressing lentivirus (LV control) at amultiplicity of infection of
10 in the presence of polybrene 5 g/ml. Virus-containing supernatant
was removed after 3 h. Puromycin was added to the culturing media at
the final concentration of 1 g/ml 2 d after infection. Five days after
puromycin selection cells were transduced with the second 1R-shRNA-
expressing lentivirus obtained with plasmid V3LHS_406026 to improve
the level of silencing achieved. LV control-infected cells were reinfected
with control-shRNA-expressing lentivirus. The second infection was
performed as the first one. Cells were tested 72 h after the second trans-
duction was performed.
RNA and real-time PCR. RNA was extracted using TRIzol Reagent
(Molecular Research Center). cDNA was synthesized from 2 g total
RNA (High Capacity cDNA Reverse Transcription Kit; Applied Biosys-
tems). The mRNAs of GAPDH and 1R were measured by real-time
(RT)-PCR with 1 L cDNA and power SYBER green PCR Master Mix
(Applied Biosystems). Primer sequences are as follows: hGAPDH For:
GGCTGGGGCTCATTTGCAGGG, hGAPDH Rev: TGACCTTGGC-
CAGGG GTGCT, 1R For: TTCCAGCGCGAAGAGATAGC, and 1R
Rev: CCGTGTACTA CCGTCTCCC. Thermal cycling conditions for
amplification were set at 50°C for 30 min and 95°C for 10 min, respec-
tively. PCR denaturing was set at 95°C for 15 s and annealing/extending
at 60°C for 60 s for 40 cycles. mRNA levels normalized for GAPDH are
expressed as fold change relative to control cells. The results were quan-
tified with the comparative Ct method (known as the 2
Ct method).
Bioluminescent resonance energy transfer assays. HEK293T cells were
transiently cotransfected with a constant amount of cDNA encoding for
the receptor fused to Rluc and with increasingly amounts of cDNA cor-
responding to the receptor fused to YFP (see figure legends). To quantify
receptor-YFP expression, fluorescence of cells (20 g protein) was read
in a Fluoro Star Optima Fluorimeter (BMG Labtechnologies) equipped
with a high-energy xenon flash lamp, using a 10 nmbandwidth excitation
filter at 400 nm reading. For bioluminescent resonance energy transfer
(BRET) or BRET with BiLFC measurements, 5 M coelenterazine H
(Invitrogen) was added to the equivalent of 20 g of cell suspension.
After 1 min for BRET or after 5 min for BRET with BiLFC after adding
coelenterazineH, the readings were collected using aMithras LB 940 that
allows the integration of the signals detected in the short-wavelength
filter at 485 nm and the long-wavelength filter at 530 nm. To quantify
receptor-Rluc expression, luminescence readings were also performed
after 10 min of adding 5 M coelenterazine H. The net BRET
is defined as [(long-wavelength emission)/(short-wavelength emis-
sion)]  cf., where cf. corresponds to [(long-wavelength emission)/
(short-wavelength emission)] for the donor construct expressed alone in
the same experiment.Datawere fitted to a nonlinear regression equation,
assuming a single phase saturation curve with GraphPad Prism software.
BRET is expressed as mili BRET units (mBU; net BRET 1000).
Sequential resonance energy transfer assays. For sequential resonance
energy transfer (SRET) assays, HEK293T cells growing in six-well plates
were transiently cotransfected with constant amounts of cDNAs encod-
ing for both receptor fused to Rluc and GFP2 proteins and with increas-
ing amounts of cDNA corresponding to the receptor fused to YFP
protein. In SRET, the oxidation of the Rluc substrate DeepBlueC by
receptor-Rluc triggers receptor-GFP2 excitation (BRET), which triggers
a subsequent excitation of receptor-YFP (FRET). Emission of YFP after
addition of DeepBlueC is only possible if the three fusion proteins are in
close proximity (10 nm), allowing sequential bioluminescent and flu-
orescent resonance energy transfer to occur. Cells were used 48 h post-
transfection. Using aliquots of transfected cells (20 g of protein),
different determinations were performed in parallel. (1) Quantification
of protein-YFP expression was performed as indicated in BRET experi-
ments. (2) For quantification of protein-Rluc expression cells were dis-
tributed in 96-well microplates (Corning 3600, white plates with white
bottom), and luminescence was determined 10 min after addition of 5
M coelenterazine H in a Mithras LB 940 multimode reader. (3) For
SRET, cells were distributed in 96-well microplates (Corning 3600, white
plates with white bottom), and 5MDeepBlueC (Invitrogen) was added.
The SRET signal was collected using aMithras LB 940 reader with detec-
tion filters for short wavelength (410 nm) and longwavelength (530 nm).
Analogous with BRET, net SRET is defined as [(long wavelength emis-
sion)/(short wavelength emission)] cf., where cf. corresponds to long
wavelength emission/short wavelength emission for cells expressing
protein-Rluc and protein-GFP2. Linear unmixing was done for SRET
quantification, taking into account the spectral signature to separate the
two fluorescence emission spectra (Zimmermann et al., 2002). SRET is
expressed as mili SRET units, mSU (net SRET 1000). Data were fitted
as in BRET experiments.
Striatal membrane preparation and coimmunoprecipitation experi-
ments.Mouse or rat striatal tissue was homogenized in 50 mM Tris-HCl
buffer, pH 7.4, containing a protease inhibitor cocktail (1/1000; Sigma).
The cellular debris was removed by centrifugation at 13,000 g for 5min
at 4°C, and membranes were obtained by centrifugation at 105,000 g
for 1 h at 4°C. Membranes were washed three more times in the same
conditions and were used for ligand binding assays or were solubilized
for coimmunoprecipitation experiments with a Dynabeads Protein G kit
(Invitrogen) using rat anti-D1 receptor antibody (1:1000; Sigma). As
negative control anti-calnexin antibody (1:1000; BD Biosciences
PharMingen) was used. Immunoprecipitates were separated on SDS-
polyacrylamide gel and transferred onto PVDF membranes to perform
Western blot assays as previously described (Navarro et al., 2010;
Moreno et al., 2011a) using as primary antibodies guinea pig anti-D1R
antibody (1:1000; Frontier Institute), rabbit anti-H3R antibody (1:
1000; Alpha Diagnostic), or mouse anti-1R antibody B-5 (sc-
137075) (1:800; Santa Cruz Biotechnology).
In situ proximity ligation assays. Mouse or rat striatal slices were
mounted on slide glass, thawed at 4°C, washed in 50 mM Tris-HCl, 0.9%
NaCl, pH 7.8 buffer (TBS), permeabilized with TBS containing 0.01%
Triton X-100 for 10min, and successively washed with TBS. Heteromers
were detected using the Duolink II in situ PLA detection Kit (OLink
Bioscience) following the instructions of the supplier. Amixture of equal
amounts of the primary antibodies–guinea pig anti-D1R antibody (see
above) and rabbit anti-H3R antibody (see above) or mouse anti-1R
antibody B-5 (see above) and guinea pig anti-D1R antibody or mouse
anti-1R antibody B-5 and rabbit anti-H3R antibody–were used to detect
D1R-H3R, 1R-D1R and 1R-H3R heteromers. respectively. Slices were
mounted using the mounting medium with DAPI. The samples were
observed in a Leica SP2 confocal microscope (Leica Microsystems). Im-
ages were opened and processed with ImageJ confocal.
Cell signaling. The cAMP concentration was determined by HTRF
methodology using the LANCE Ultra cAMP kit (PerkinElmer) and a
PHERAstar FlagshipMicroplate Reader (BMG Labtechnologies) follow-
ing the instructions of the supplier. To determine ERK 1/2 phosphoryla-
Table 1. Cocaine blocks the positive allosteric interaction between D1R and H3R.
Competition experiment (3HSCH vs SKF38393)
Parameters
KD1 (nM) KD2 (nM)
Not treated rats in the absence of cocaine
Control 31 4 1100 200
	RAMH 14 1* 320 10*
Not treated rats in the presence of cocaine
Control 28 2 1000 100
	RAMH 30 4 1100 200
Cocaine acutely treated rats
Control 28 4 440 60
	RAMH 19 4 390 40
Sham rats
Control 26 4 700 100
	RAMH 3 2** 130 40**
Cocaine self-administered rats
Control 33 6 800 200
	RAMH 37 9 1900 600
Competition curves of theD1R antagonist 
3HSCH23390 (2 nM) binding versus increasing concentrations of theD1R
agonist SKF 38393 were performed in the absence or the presence of 2 nM of the H3R agonist RAMH using striatal
membranes from control rats treated or not with 30M cocaine for 30 min, rats acutely treated with cocaine, or
cocaine self-administered rats. KD1 and KD2 are, respectively, the equilibrium dissociation constants of SKF 38393
binding toD1Randweredeterminedby fittingbindingdata to Equation3. Parameters aremean SEM(n
3). For
each group, significant differences with respect to control were calculated by an unpaired Student’s t test (*p
0.05, **p 0.01).
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tion, cells and mouse or rat striatal slices were treated or not with the
indicated ligand for the indicated time and were lysed by the addition of
500 l of ice-cold lysis buffer (50 mM Tris-HCl, pH 7.4, 50 mM NaF, 150
mM NaCl, 45 mM -glycerophosphate, 1% Triton X-100, 20 M phenyl-
arsine oxide, 0.4 mMNaVO4, and protease inhibitor cocktail). The cellu-
lar debris was removed by centrifugation at 13,000 g for 5 min at 4°C
and the protein was quantified by the bicinchoninic acid method using
BSA dilutions as standard. ERK1/2 phosphorylation were then detected
as described previously (Moreno et al., 2011a). Arrestin recruitment was
determined by BRET experiments (see above) in HEK293T cells 48 h
after transfection with the indicated amounts of cDNA corresponding to
D1R, -arrestin 1-Rluc, and H3R-YFP. Cells (20 g of cell suspension
protein per well in a 96-well microplates) were not treated or treated for
30 min with 30 M cocaine or 1 M of the antagonists SCH 23390 or
thioperamide alone or in combination, and 5 M coelenterazine H was
added before stimulation with the agonists SKF 38393 (100 nM) or imetit
(100 nM) for 12 min and BRET between -arrestin 1-Rluc and H3R-YFP
was determined as above.
Radioligand binding experiments and binding data analysis. Ligand
binding was performed with rat striatal membranes (0.2 mg of pro-
tein/ml) in 50 mM Tris-HCl buffer, pH 7.4, containing 10 mM MgCl2,
at 25°C. For competition experiments, membranes were incubated
with free 2 nM [ 3H]SCH 23390 (PerkinElmer) or free 3 nM [ 3H]R-a-
methyl histamine ([ 3H]RAMH; GE Healthcare) or free 2 nM [ 3H]
YM-09151-02 (PerkinElmer) in the presence or the absence of in-
creasing free concentrations of SKF 38393 (0.01 nM–30 M; Tocris
Bioscience) with or without 2 nM RAMH (Sigma), increasing free
concentrations of SCH 23390 (0.01 nM–10M; Sigma), increasing free
concentrations of RAMH (0.01 nM–30 M), or increasing free con-
centrations of PRE-084 (0.01 nM to 10 M; Tocris Bioscience). In all
cases, membranes were incubated with ligands providing enough
time to achieve stable equilibrium for the lower ligand concentra-
tions. Nonspecific binding was determined in the presence of 30 M
nonlabeled ligand and confirmed that the value was the same as cal-
culated by extrapolation of the competition curves. Free and mem-
brane bound ligands were separated by rapid filtration of 500 l
aliquots in a cell harvester (Brandel) through Whatman GF/C filters
embedded in 0.3% PEI that were subsequently washed for 5 s with 5
ml of ice-cold Tris-HCl buffer. The filters were incubated overnight
with 10 ml of Ecoscint H scintillation mixture (National Diagnostics)
at room temperature and radioactivity counts were determined using
a Tri-Carb 1600 scintillation counter (PerkinElmer) with an effi-
ciency of 62%. Protein was quantified by the bicinchoninic acid
method (Pierce Chemical) using BSA dilutions as standard.
Competition curves were analyzed by nonlinear regression, using the
commercial GraFit software (Erithacus software), by fitting the binding
data to the two-state dimer receptormodel (Franco et al., 2005, 2006) To
calculate themacroscopic equilibrium dissociation constants Equation 1
deduced by Casado´ et al. (2007) was used.
Abound (KDA2A 2A
2 KDA2AB/KDAB)RT (KDA1KDA2
Figure1. Cocaine alters the functional characteristics of D1R-H3R heteromers in transfected cells.a– c, f, Neuroblastoma SK-N-MC cells stable expressing D1R andH3Rwere not treated or treated
overnightwith 30M cocaine.a,b, cAMPproductionwas determined after 10min stimulationwithD1R agonist SKF 38393 (1M) or theH3R agonist imetit (1M) (a) orwithD1R agonist SKF 81297
(100 nM) or the H3R agonist RAMH (100 nM) (b) in the absence or in the presence of 0.5M forskolin. Values (cAMP produced in each conditionminus basal stimulation in the absence of forskolin or
agonists) represent mean SEM, n
 4–8. One-way ANOVA followed by Bonferroni post hoc test showed a significant (*p 0.05, **p 0.01, ***p 0.001) effect over basal (cells not
stimulated) or ( #p0.05, ###p0.001) over forskolin effect (cells stimulatedwith forskolin). c, f, Cells infectedwith the empty virus vector (c) or infectedwith lentiviral particles expressing shRNA
(sh1R) to silence the receptor (f )were treated for 30minwith the D1R antagonist SCH 23390 (1M) or theH3R antagonist thioperamide (1M) before the addition of SKF 38393 (100 nM) or imetit
(100 nM) for an additional incubation period of 10 min and ERK 1/2 phosphorylation was determined byWestern blot. Values represent mean SEM (n
 3–5) of percentage of phosphorylation
relative to basal levels found inuntreated cells. One-wayANOVA followedbyBonferronipost hoc tests showeda significant (*p0.05, **p0.01) effect over basal or of the antagonist plus agonist
treatment over the agonist treatment ( #p 0.05).d,-Arrestin 1 recruitmentwasmeasured by BRET experiments in HEK293T cells 48 h post-transfectionwith 2g of cDNA corresponding toD1R,
1g of cDNA corresponding to-arrestin 1-Rluc, and 3g of cDNA corresponding to H3R-YFP. Cells were not treated (BRET 10) or treated for 30 min with 30M cocaine, 1M SCH 23390, or
1M thioperamide alone or in combination before 10min stimulation with SKF 38393 (100 nM) or imetit (100 nM). Values represent mean SEM, n
 4. One-way ANOVA followed by Bonferroni
post hoc tests showed a significant effect over basal (**p 0.01, ***p 0.001) or of the antagonist plus agonist treatment over the agonist treatment ( ##p 0.01, ###p 0.001). e, 1R
expressionwas determined after silencing of1R by shRNA. Neuroblastoma SK-N-MC cells stable expressingD1R andH3Rwere infectedwith lentiviral particles containing either control (LV control)
or shRNA specific for1R (LV sh1R) and the relative expression levels were tested using quantitative RT-PCR. Results are expressed as an average of three replicates.
3548 • J. Neurosci., March 5, 2014 • 34(10):3545–3558 Moreno et al. •1-D1-H3 Complexes: Targets for Cocaine Effects
 KDA2A A
2 KDA2AB/KDAB KDA1KDA2B/KDB1
 KDA1KDA2B2/(KDB1KDB2)), (1)
whereA represents the radioligand concentration,RT is the total amount
of receptor dimers, and KDA1 and KDA2 are the macroscopic dissociation
constants describing the binding of the first and the second radioligand
molecule (A) to the dimeric receptor; B represents the assayed compet-
ing compound concentration, and KDB1 and KDB2 are, respectively, the
equilibrium dissociation constants of the first and second binding of B.
KDAB can be described as a hybrid equilibrium radioligand/competitor
dissociation constant, which is the dissociation constant of B binding to
a receptor dimer semi-occupied by A.
To quantify cooperativity, the dimer cooperativity index for the com-
peting ligand B is defined by Casado´ et al. (2007) as follows:
DCB log (4KDB1/KDB2). (2)
Depending on the characteristics of the ligands (the radioligand A and
the competitor B) the following simplifications of the Equation 1 were
considered:
For A ([ 3H]SCH 23390) noncooperative and B (SKF 38393) cooper-
ative (biphasic competition curves; Table 1): Equation 1 can be simpli-
fied to Equation 3 due to the fact thatKDA2
 4KDA1 and, therefore,KDA1
is enough to characterize the binding of the radioligand A (Casado´ et al.,
2007):
Abound (4KDA1A 2A
2
 4KDA1AB/KDAB)RT/(KDA1
2 4KDA1A
 A2 4KDA1AB/KDAB 4KDA1
2B/KDB1
 4KDA1
2B2/(KDB1KDB2)). (3)
ForA ([ 3H]YM-09151–02) andB (Bmax deter-
mination for 1R in Fig. 7): Equation 1 was
simplified to Equation 4 due to the fact that
KDA2
 4KDA1 and KDB2
 4KDB1 (Casado´ et
al., 2007):
Abound (4KDA1A 2A
2
 4KDA1AB/KDAB)RT/(4KDA1
2 4KDA1A
 A2 4KDA1 AB/KDAB 4KDA1
2B/KDB1
 4KDA1
2B2/KDB1
2). (4)
For A ([ 3H]SCH 23390 or [ 3H]RAMH) and B
(SCH 23390 or RAMH) noncooperative being
the A and B the same compound (Bmax deter-
mination for D1R or H3R in Fig. 7): Equation 1
was simplified to Equation 5 due to the fact that
KDA2
 4KDA1, KDB2
 4KDB1, KDA1
 KDB1,
KDA2 
 KDB2 and KDAB 
 4KDA1 (Casado´ et
al., 2007):
Abound (4KDA1A 2A
2AB)
RT/(4KDA1
2 4KDA1A A
2
 AB 4KDA1B B2). (5)
Goodness of fit was tested according to re-
duced  2 value given by the nonlinear regres-
sion program.
Results
D1R-H3R heteromers are signaling
units that can be modulated by cocaine
It has previously been described that the
formation of D1R-H3R heteromers in
neuroblastoma cells leads to a change in
the D1R G-protein coupling from the Gs
to theGi protein, to whichH3R is coupled. In fact, in the presence
of the H3R, D1R was no longer coupled to Gs, and could not
activate adenylyl cyclase, yet the heteromer remains coupled toGi
(Ferrada et al., 2009). This change in G-protein coupling was
identified as a specific characteristic of the heteromer. We first
examinedwhether cocaine is able to influence theG-protein cou-
pling to D1R-H3R heteromers by measuring cAMP production,
which is tied to the activation of G-proteins. In SK-N-MC neu-
roblastoma cells expressing D1R and H3R, the D1R agonist SKF
38393was able to reduce the forskolin-stimulated cAMPproduc-
tion in accordance with a Gi protein coupling (Fig. 1a). Interest-
ingly, in the presence of 30 M cocaine, SKF 38393 increases
cAMPproduction and did not affect forskolin-induced cAMP, in
agreement with a Gs coupling (Fig. 1a). In contrast with D1R
agonist, the H3R agonist imetit induced a decrease in cAMP pro-
duction in the presence or in the absence of cocaine in accordance
with a Gi-protein coupling (Fig. 1a). Similar results were ob-
tained using the H3R agonist RAMH and the D1R agonist SKF
81297 (Fig. 1b). These data suggest that cocaine may alter the
G-proteins associated with the heteromer or at a minimum alter
D1R-H3R signaling. Next, we examined whether cocaine could
Figure 2. 1R-D1R-H3R complexes detected by energy transfer experiments. a, c, d, BRET saturation experiments were per-
formed using HEK293T cells 48 h post-transfection with 0.2 g of cDNA corresponding to H3R-Rluc (a) or 0.15 g of cDNA
corresponding to D1R-Rluc (c, d) and increasing amounts of cDNA corresponding to1R-YFP (a; 0.1– 0.5g cDNA) or H3R-YFP (c,
d; 0.2–1.5g cDNA). Cells were treated for 30 min (a, c) or 24 h (d) with medium (red lines) or with 30M cocaine (black lines)
prior BRET determination. c, d, Cells were also transfected with siRNA for 1R (see Materials and Methods; green line). Both
fluorescence and luminescence of each sample were measured before every experiment to confirm similar donor expressions
(110,000 bioluminescence units) whilemonitoring the increase in acceptor expression (10,000–40,000 fluorescence units). b,
SRET saturation experiments were performed using HEK293T cells 48 h post-transfection with 0.3g of cDNA corresponding to
H3R-Rluc, 0.23g of cDNA corresponding to 1R-GFP
2, and increasing amounts of cDNA corresponding to D1R-YFP (0.05–0.6
g). Cells were treated for 30 min with medium (red lines) or with 30M cocaine (black lines) prior to SRET determination. The
relative amount of BRET or SRET is given as a function of 100 the ratio between the fluorescence of the acceptor (YFP) and the
luciferase activity of the donor (Rluc). BRET and SRET are expressed as mBU or mSU, respectively, and values are means SEM;
three to four different experiments grouped as a function of the amount of acceptor. a, b, Top, A schematic representation of the
BRET (a) and SRET (b) techniques is shown.
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disrupt the cross-antagonism between both receptors in the het-
eromer previously described (Moreno et al., 2011a). In SK-
N-MC neuroblastoma cells expressing D1R and H3R, the D1R
agonist SKF 38393 induced ERK 1/2 phosphorylation that was
similar in the absence or the presence of cocaine suggesting that
this signal was G-protein independent. SKF 38393-induced ERK
1/2 phosphorylation was blocked by its own antagonist SCH
23390 as well as by the H3R antagonist thioperamide, but this
Figure3. Expressionof1R-D1R-H3Rcomplexes in themousestriatumdetectedbycoimmunoprecipitationandPLAexperiments.a–d, Coimmunoprecipitationexperimentsareshown.Striatal slices from
WT and1R KOmice were untreated or treated with 150M cocaine for 30 min (cocaine). Solubilized striatal membranes (a) and immunoprecipitates with anti-D1R antibody or anti-calnexin antibody as
negative control (NC;b–d)were analyzedbySDS-PAGEand immunoblottedusinganti-D1Rantibody (b), anti-H3Rantibody (c), or anti-1Rantibody (c). IP, immunoprecipitation;WB,Westernblotting;MW,
molecular mass. e–m, PLAs were performed as indicated inMaterials andMethods, usingWT (e–g) or1R KOmice (h–j) striatal slices. D1R-H3R (e, h),1R-D1R (f, i), and1R-H3R (g, j) heteromers were
visualizedas red spots aroundblue-coloredDAPI-stainednucleus.k–m, Negative controlswereperformeddoing thePLAexperiments inWTmouse striatal slices incubatedwithonly antiD1R (k), anti-1R (l ),
or anti-H3R (m) antibody as primary antibodies. Cell nucleiwere stainedwithDAPI (blue). For each part amagnification is shown. Scale bar, 20m.
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cross-antagonismwas not seen in cells treatedwith 30Mcocaine
(Fig. 1c). Analogously, the H3R agonist imetit-induced ERK 1/2
phosphorylation was reverted by both thioperamide and the D1R
antagonist SCH 23390. Again, the cross-antagonism was lost in
the presence of cocaine and, in these conditions, the signaling
induced by imetit was very low (Fig. 1c) in agreement with the
requirement of D1R-H3R heteromers for imetit to signal via the
ERK 1/2 pathway (Moreno et al., 2011a).
Apart from G-protein-mediated sig-
naling, many GPCRs are able to signal by
an arrestin recruitment-dependentmech-
anism with p-ERK 1/2 being one of the
signaling pathways downstream of arres-
tin (Shenoy and Lefkowitz, 2003; Shenoy
et al., 2006;DeWire et al., 2007). If cocaine
is able to alter the D1R-H3R heteromer-
driven activation of ERK 1/2 then one
possibility is that it also alters arrestin
recruitment. Using BRET to measure
-arrestin 1 recruitmentwe investigated if
cocaine is able to modulate the ligand-
induced -arrestin 1 recruitment to these
receptors. In HEK293 cells transiently ex-
pressing D1R, -arrestin 1-Rluc, and
H3R-YFP, a positive BRET signal between
-arrestin 1 and H3R was detected after
stimulation with H3R agonist imetit or
with D1R agonist SKF 38393 (Fig. 1d). In-
terestingly, the BRET signal was dimin-
ished when cells were coactivated with
both agonists, indicating a negative cross-
talk between both receptors and in line
with that seen in neurons (Arias-Montan˜o et
al., 2001). In addition, we could also de-
tect cross-antagonism in the -arrestin 1
recruitment assays, that is, the BRET in-
duced by SKF 38393 was blocked by the
H3R antagonist thioperamide and the
BRET induced by imetit was blocked by
the D1R antagonist SCH 23390 (Fig. 1d).
These results match what was seen with
the p-ERK 1/2, suggesting that the earlier
signaling changes may be due to changes
in -arrestin 1 recruitment. This negative
cross-talk and cross-antagonism at the
level of -arrestin 1 recruitment were not
observed in cells treated with 30 M co-
caine (Fig. 1d), supporting the hypothesis
that cocaine can alter the function ofD1R-
H3R heteromers. In the presence of co-
caine, the imetit-induced -arrestin 1
recruitment was very low (Fig. 1d) indi-
cating the need for functional D1R-H3R
heteromers for imetit to induce arrestin
recruitment as well as ERK 1/2 signaling.
We and others have shown that one of
the targets of cocaine is the chaperone-like
protein, 1R, which can interact with and
modulate D1R (Hiranita et al., 2010, 2013;
Navarro et al., 2010; Katz et al., 2011;
Kourrich et al., 2012, 2013). From these
studies it is tempting to hypothesize that
1R can mediate cocaine’s effect by mo-
lecularly interacting with D1R-H3R het-
eromers. To test this, we first repeated the signaling in
neuroblastoma cells using cells in which 1R was silenced by
shRNA infection (Fig. 1e). In these cells, cocaine did not affect the
cross-antagonism or the imetit-induced signaling (Fig. 1f), dem-
onstrating that 1R are indeed mediating cocaine’s effects on
D1R-H3R signaling. These results show that 1R is required for
cocaine’s effects but does not demonstrate a molecular interac-
Figure 4. Expression of1R-D1R-H3R complexes in the rat striatumdetected by coimmunoprecipitation and PLA experiments.
a–d, Coimmunoprecipitation experiments are shown. Rat striatal sliceswere untreated or treatedwith 150M cocaine for 30min
(cocaine). Solubilized striatal membranes (a) and immunoprecipitates with anti-D1R antibody or anti-calnexin antibody as nega-
tive control (NC; b–d) were analyzed by SDS-PAGE and immunoblotted using anti-D1R antibody (b), anti-H3R antibody (c), or
anti-1R antibody (c). IP, immunoprecipitation; WB, Western blotting; MW, molecular mass. e–g, PLAs were performed as
indicated in Materials and Methods, using rat striatal slices. D1R-H3R (e),1R-D1R (f ), and1R-H3R (g) heteromers were visual-
ized as red spots around blue– colored DAPI-stained nucleus. Scale bar, 20m.
Figure 5. Cocaine inhibits the H3R signaling and the D1R-H3R cross-antagonism in ERK 1/2 phosphorylation inmouse striatum.
WT (a) and1R KO (b)mouse striatal sliceswere treated or notwith 150M cocaine for 2 h andwere preincubated for 20minwith
medium, the D1R antagonist SCH 23390 (10 M), or the H3R antagonist thioperamide (10 M) before the addition of the D1R
agonist SKF 38393 (1M) or the H3R agonist imetit (1M) for an additional incubation period of 10min. ERK 1/2 phosphorylation
was determined by Western blot. Immunoreactive bands from three to eight slices obtained from eight WT or KO animals were
quantified for each condition. Values represent mean SEM percentage of phosphorylation relative to basal levels found in
untreated slices. No significant differences were obtained between the basal levels of the WT and the 1R KO mice. One-way
ANOVA followed by Bonferroni post hoc tests showed a significant (*p 0.05) effect over basal or of the antagonist plus agonist
treatment over the agonist treatment ( #p 0.05, ##p 0.01).
Moreno et al. •1-D1-H3 Complexes: Targets for Cocaine Effects J. Neurosci., March 5, 2014 • 34(10):3545–3558 • 3551
tion between 1R and D1R-H3R heteromers. To test first if 1R
can directly interact with H3R we performed BRET experiments
inHEK293T cells expressing a constant amount of H3R-Rluc and
increasing amounts of 1R-YFP. As shown in Figure 2a, we did
not detect energy transfer in these cells nor in cells treatedwith 30
M cocaine for 30 min, suggesting a lack of interaction between
H3R and 1R. Next we used SRET (Carriba et al., 2008) to study
if H3R and 1R can interact in the presence of D1R. For this, Rluc
was fused to H3R to act as a BRET donor, GFP
2 was fused to D1R
to act as a BRET acceptor and as a FRET donor, and YFP was
fused to1R to act as a FRET acceptor (Fig. 2b). InHEK293T cells
expressing a constant amount of H3R-Rluc and D1R-GFP
2 and
increasing amounts of1R-YFP, a positive SRET saturation curve
was obtained (Fig, 2b, red curve) with a SRETmax of 114  18
mSU and SRET50 of 41 18. These results indicate that 1Rs can
complex with D1R-H3R heteromers through an interaction with
D1R in the heteromer. As cocaine can bind 1R at pharmacolog-
ical relevant concentrations (Matsumoto et al., 2003; Hayashi
and Su, 2005; Hiranita et al., 2010, 2013; Kourrich et al., 2012) we
next wanted to examine whether cocaine is able to modulate the
D1R-H3R heteromer at the molecular level via 1R. When the
SRET experiments described above were performed in cells
treated 30 min with 30 M cocaine (Fig. 2b, black curve), a posi-
tive SRET saturation curve was obtained with a slight increase in
Figure 6. Cocaine inhibits the H3R-mediated modulation of D1R-promoted ERK 1/2 phosphorylation in rat striatum. Striatal slices from naive rats treated or not with 150M cocaine for 2 h (a,
b) and striatal slices from sham rats or rats acutely treated (24 h) with cocaine (c, d), or striatal slices from sham rats or 9 weeks cocaine self-administered rats (e, f ) were preincubated for 20 min
withmedium, the D1R antagonist SCH 23390 (10M), or the H3R antagonist thioperamide (10M) before the addition of the D1R agonist SKF 38393 (1M) or the H3R agonist imetit (1M) for an
additional incubation period of 10min and ERK 1/2 phosphorylationwas determined byWestern blot. Immunoreactive bands from3 to 10 slices obtained from four animalswere quantified for each
condition. Values representmean SEMpercentage of phosphorylation relative to basal levels found in untreated slices. One-wayANOVA followedbyBonferronipost hoc tests showeda significant
(*p 0.05, **p 0.01, ***p 0.001) effect over basal or of the antagonist plus agonist treatment over the agonist treatment ( #p 0.05, ##p 0.01, ###p 0.001).
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the maximum energy transfer (SRETmax 
 145  19 mBU and
SRET50
 48 17), suggesting that cocaine binding changes the
quaternary structure of the heteromer decreasing the distance or
favoring the orientation between the donor and acceptor pro-
teins. The cocaine-induced structural changes were also observed
in BRET saturation curves for the D1R-Rluc-H3R-YFP pair in
cells expressing a constant amount of D1R-Rluc and increasing
amounts of H3R-YFP where there was an increase in energy
transfer after cells were treated with 30 M cocaine for 30 min
(Fig. 2c, red curve; BRETmax
 52 2 mBU and BRET50
 14
2 vs black curve, BRETmax
 68 6mBU and BRET50
 16 4).
This effect was reverted in cells whose endogenous 1R expres-
sion was silenced using siRNA previously described (Navarro et
al., 2010; Fig. 2c, green curve; BRETmax 
 49  4 mBU and
BRET50
 11 3). Similar results were obtained in cells treated
with 30 M cocaine for 24 h (Fig. 2d). These results suggest that
cocaine binding to 1R is not disrupting D1R-H3R heteromers,
but is inducing structural changes inD1R-H3R heteromers. Thus,
it is clear that in transfected cells cocaine, by binding to1R, alters
the D1R-H3R heteromer such that it can diminish H3R receptor
ability to modify D1R signaling.
The1Rmediates cocaine’s effects on D1R-H3R heteromer
function in the striatum
Although the 1R-mediated ability of cocaine to modulate the
structure and signaling of D1R-H3R heteromers in cells is sugges-
tive of a novel cocaine mechanism, it is important to show that
similar events can occur in tissue. First we tested whether 1R-
D1R-H3R complexes are expressed inWTand1RKOmice stria-
tum by coimmunoprecipitation experiments and by proximity
ligation assays (PLA) using specific antibodies we described pre-
viously (Moreno et al., 2011a; Navarro et al., 2013). By Western
blot experiments we found the expression of both D1R and H3R
in the striatum of WT and KO mice and the expression of 1R
receptors inWTbut not in the striatumof1RKOmice (Fig. 3a).
In coimmunoprecipitation experiments (Fig. 3b–d) the antibody
against D1R could indeed coprecipitate D1R (Fig. 3b) and H3R
(Fig. 3c) inWTorKOmice striatalmembranes, and this antibody
also coimmunoprecipitates 1R fromWT striatum but not from
KO striatum (Fig. 3d). It is interesting to note that the D1R-H3R
or D1R-1R coimmunoprecipitation increased after treatment
with 30 M cocaine (Fig. 3c and d). This could be due to a
cocaine-induced higher 1R expression at the membrane
(Hayashi and Su, 2005; Navarro et al., 2010) where heterocom-
plex formation might be favored. The coimmunoprecipitation
results are in line with the BRET experiments above and highly
suggestive that 1R-D1R-H3R complexes are expressed in the
striatumofWT animals and that D1R-H3R heteromer expression
is maintained in the striatum of 1R KO mice. Interestingly, the
coprecipitation of H3R by anti-D1R is more efficient in the pres-
ence of cocaine, suggesting a change in the strength of interac-
tion, consistent with the increase in the SRET detected in Figure
2b. Furthermore we used the PLA to explore whether D1R-H3R
heteromer expression was maintained in 1R KO mice and
whether1R-D1R-H3R complexes could be detected inWTmice.
PLA requires that both receptors be close enough to allow the two
different antibody-DNA probes to be able to ligate (17 nm;
So¨derberg et al., 2008; Trifilieff et al., 2011). If the receptors are
within sufficient proximity, a punctate fluorescent signal can be
detected by confocal microscopy. Using striatal slices from both
WT (Fig. 3e–g) and 1R KO (Fig. 3h–j), a red punctate fluores-
cent stain surroundingDAPI-positive nuclei was observed for the
H3R-D1R (Fig. 3e), D1R-1R (Fig. 3f), or H3R-1R (Fig. 3g) pairs
in WT mouse striatum but only H3R-D1R heteromers were de-
tected in 1R KO animals (Fig. 3h). These data confirm the co-
precipitation experiments above. As a negative control we
checked that the red spots were not seen in slices treatedwith only
one primary antibody and both secondary antibody-DNAprobes
(Fig. 3 k–m). To determine the cocaine effect on the striatal D1R-
H3R heteromerization we performed PLA experiments in the
presence of cocaine. In these conditions, results from PLA exper-
iments were very similar to the ones obtained in the absence of
cocaine (results not shown), indicating that 1R, D1R, and H3R
are indeed in a complex in mice striatum in the presence or
absence of cocaine. Next, by using the coimmunoprecipitation
and PLA experiments described above, we observed that 1R-
D1R-H3R complexes are expressed in the rat striatum since the
antibody against D1R could indeed coprecipitate D1R, H3R, and
1R in the absence or the presence of cocaine andwe detected red
spots in the PLA experiments for the pairsH3R-D1R,D1R-1R, or
H3R-1R (Fig. 4). These results suggest that 1R-D1R-H3R com-
plexes are expressed in rat striatum and that cocaine, by binding
to 1R, does not disrupt the heteromer per se.
To test the cocaine effect on H3R-D1R heteromer signaling in
the striatum we determined the receptor agonists induced ERK
1/2 phosphorylation using striatal slices. To test if cocaine effect is
mediated by 1R we performed the signaling experiments inWT
and 1R KO mice. If cocaine is indeed acting via 1R to modify
the D1R-H3R heteromer in the striatum, then we should see no
effect of cocaine in the 1R KOmice. The striatal level of cocaine
reached after pharmacologically significant doses is 15M (Pettit
et al., 1990). To allow diffusion into the tissue in brain slices we
used a 10-fold higher cocaine concentration, 150 M. We deter-
mined the cross-antagonism in ERK 1/2 phosphorylation using
striatal slices from WT and 1R KO mice in the absence or the
presence of cocaine. In the absence of cocaine the ERK 1/2 phos-
phorylation induced by the D1R agonist SKF 38393 was reverted
by the H3R antagonist thioperamide in striatal slices from WT
(Fig. 5a) and from 1R KO mice (Fig. 5b). These data indicate
that functional D1R-H3R heteromers are expressed in the stria-
tum of both WT and 1R KO mice in agreement to the PLA
results above. In addition, the presence of cocaine did not
affect H3R signaling and the cross-antagonism in striatal slices
from 1R KO mice (Fig. 5b). In contrast, cocaine blocked the
H3R signaling and the D1R-H3R cross-antagonism in slices from
Figure 7. Receptor expression in the striatumof cocaine acutely treated rats comparedwith
sham rats. The expression of H3R (white bars), D1R (gray bars), and1R (black bars) in striatal
membranes from a pool (n 
 5) of sham rats or rats acutely treated (24 h) with cocaine
(cocaine) was determined by competition experiments of [ 3H]RAMH (3 nM) versus RAMH,
[ 3H]SCH 23390 (2 nM) versus SCH 23390, or [ 3H] YM-09151-02 (2 nM) versus PRE-084, respec-
tively. Competition curves were monophasic and binding data were fitted to Equations 4 or 5
(see Materials and Methods) to calculate the maximum binding.
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WT mice (Fig. 5a). These results indicate
that cocaine binding to 1R blocks the
H3R-mediatedmodulation of D1R signal-
ing in the striatum.
Short or long treatment with cocaine
disrupts the allosteric interaction
between D1R and H3R in the striatum
One of the striking effects of cocaine is its
ability to show prolonged effects even af-
ter a single exposure. We next wanted to
examine whether and how D1R-H3R het-
eromer function might change in acute
versus prolonged exposure to cocaine.
For this we used a rat model of self-
administration and compared the results
to acute treatment. First, we confirmed
that the effect of cocaine on the heteromer
signaling in ex vivo rat striatal slices was
equivalent to that of those in mice striatal
slices seen above. In the absence of co-
caine, the activation of slices with the D1R
agonist SKF 38393 or the H3R agonist
imetit induced ERK 1/2 phosphorylation,
in line with the results found in mice. In
addition, the coactivation with both ago-
nists inhibited this signaling (Fig. 6a) in-
dicating a negative cross-talk between
both receptors. Importantly, when slices
were treated with 150 M cocaine, imetit
was not able to induce ERK 1/2 phosphor-
ylation and the negative cross-talkwas not
observed (Fig. 6a). The ERK 1/2 phos-
phorylation induced by the D1R agonist
SKF 38393 or the H3R agonist imetit was
blocked by both the H3R antagonist thioperamide and the D1R
antagonist SCH 23390 (Fig. 6b). This cross-antagonism was not
observed when slices were treated with 150 M cocaine again
matching the results found in mice.
Nextwe examinedwhether a single exposure in vivo to cocaine
could influence the function of D1R-H3R heteromers. Using rats
acutely injected with one dose of cocaine, we analyzed the ability
ofH3R to influenceD1R-induced ERK1/2 phosphorylation using
striatal slices 24 h after injection. Unlike the sham rats, in the
cocaine-treated rats the ERK 1/2 phosphorylation induced by the
D1R agonist SKF 38393 was not reverted by the H3R antagonist
thioperamide (Fig. 6c). The ERK 1/2 phosphorylation induced by
the H3R agonist imetit was reverted by the D1R antagonist SCH
23390 in the sham rats, but imetit was not able to signal in
cocaine-treated rats (Fig. 6d), suggesting that 24 h after cocaine
treatment the heteromer is not functional or disrupted, an effect
not due to changes in the receptor expression by cocaine treat-
ment (Fig. 7). Next, we wanted to test whether the molecular
changes observed in the presence of cocaine were short term or
whether they might persist in models of long-term addiction. To
explore this we tested the effects of cocaine in long-term cocaine
self-administered rats using striatal slices obtained 1 d after the
last session of rats exposed to a cocaine self-administration re-
gime of 6–11 weeks. Comparing signaling in striatal slices from
rats with cocaine self-administration and sham rats we again ob-
served a reduced cross-antagonism in the cocaine-treated ani-
mals (Fig. 6e,f). Together, it is clear that short and long cocaine
treatment allowsD1R to signal freely by hindering the dampening
effect that H3R normally provides in the brain striatum.
One of the mechanisms by which heteromers function is
through the directmodulation of the ligand affinity of the partner
receptor (Gonza´lez et al., 2012). We sought to test this property
for rat striatal D1R-H3R heteromers and whether cocaine could
modulate it. We performed radioligand binding experiments us-
ing striatal membranes obtained 1 d after the last session of rats
exposed to cocaine self-administration for 6–11 weeks, rats
acutely treated with one dose of cocaine, or sham rats and we
compared the results with the ones obtained with naive rat stria-
tal membranes exogenously treated with 30 M cocaine for 30
min. Competition curves of D1R antagonist [
3H]SCH 23390
binding versus increasing concentrations of D1R agonist SKF
38393 in the absence or the presence of the H3R agonist RAMH
were performed as indicated (see Materials and Methods). In all
cases the competition curveswere biphasic and binding datawere
fitted to the two-state dimer receptor model (see Materials and
Methods) to calculate the macroscopic equilibrium dissociation
constants using the equations described (seeMaterials andMeth-
ods). The values appear in Table 1. In striatal membranes from
naive rats not treated with cocaine or from sham rats, the H3R
agonist induced a decrease of the D1R macroscopic equilibrium
dissociation constant values, indicating an allosteric interaction
between both receptors. However, treating the striatal mem-
branes from naive rats with cocaine or using striatal membranes
from cocaine self-administered rats or from rats acutely treated
with cocaine, this allosteric interaction was not observed (Table
Figure 8. Cocaine inhibits the H3R-mediated modulation of D1R-promoted cell death in organotypic striatal slice cultures.
Organotypic cultures of rat striatal slices were prepared as indicated (see Materials and Methods) and after 24 h, culture medium
was replaced by fresh medium containing no ligands (a) or 150M cocaine (c). After 1 h, vehicle or 10M SCH 23390, imetit, or
thioperamidewere added and incubated for an additional 1 h before the addition of the D1R agonist SKF 38393 (50M) and slices
were maintained 48 h more in culture. As a control, cell death induced by 1 mM glutamate in the presence or in the absence of 10
M imetit was analyzed (b). Cell death was determined by DAPI and PI staining as indicated (see Materials and Methods). Values
represent mean SEM percentage of PI stained cells versus total DAPI-stained cells determined in six to eight fields from two to
three independent organotypic cultures. Bifactorial ANOVA showed a significant (***p 0.001) effect over basal corresponding
to nontreated organotypic cultures. One-way ANOVA followed by Bonferroni post hoc tests showed a significant (***p 0.001)
effect over basal corresponding to nontreated organotypic cultures or of organotypic cultures treated with two ligands respect to
the cultures treated with SKF 38393 ( ###p 0.001).
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1). Since the effect was observed after a short treatment with
cocaine, these results suggest that cocaine binding to 1R is
blocking the allosteric interaction between H3R and D1R in the
1R-D1R-H3R complex.
Effect of cocaine in the H3R-mediated modulation of
D1R-induced cell death in the striatum
The results above described indicate that H3R can act as a “mo-
lecular brake” of D1R function by forming heteromers in the rat
striatum, blocking the ability of D1R to signal and that cocaine
can remove this brake and allow D1R to signal unimpeded by
H3R. Ideally we would like to have a physiological readout of
these changes in the D1R-H3R heteromer function. It has been
shown that the dopamine increase due to drug intake is neuro-
toxic (Cunha-Oliveira et al., 2008) and it has been described that
striatal cells are especially vulnerable to dopamineD1R activation
by a nonoxidative process (Paoletti et al., 2008). Here, using or-
ganotypic rat striatal cultures we tested the hypothesis that block-
ing D1R signaling via H3R could lead to a change in D1R
overactivation-induced cell death.We first tested theH3R ligands
effect on D1R-induced cell death in organotypic rat striatal cul-
tures. As indicated inMaterials andMethods, we determined cell
death by comparing DAPI and PI staining. The D1R agonist SKF
38393, but not H3R agonist imetit or the antagonist thiopera-
mide, induced cell death, an effect that was reverted by the D1R
antagonist SCH 23390 (Fig. 8a). When SKF 38393 and imetit
were added together to the organotypic cultures, imetit blocked
the D1R-mediated cell death (Fig. 8a) and the imetit effect was
specific for D1R-mediated cell death as it was not observed in
glutamate-induced cell death (Fig. 8b). Similar blocking of cell
death was observed when SKF 38393 and thioperamide were
added together (Fig. 8a). Thus, reducing D1R signaling via H3R
can serve to reduce downstream physiological effects in our or-
ganotypicmodels, indicating that H3R indeed serves as a “molec-
ular brake” or control point for D1R function.We next examined
whether cocaine could remove this brake performing the same
experiments in organotypic cultures treatedwith 150Mcocaine.
As shown in Figure 8c, cocaine was able to disrupt the imetit
inhibition of the SKF 38393-promoted cell deathwithout altering
the effect of SKF 38393 alone and also blocked the cross-
antagonism exerted by the H3R antagonist thioperamide on SKF
38393-promoted cell death (Fig. 8c).
The results above suggest that cocaine’s disruption of D1R-
H3R signaling is an important enough disruption that can trans-
late into pathological consequences. Thus, in cases where altering
D1R signalingmight be desired, it could be advantageous to target
D1R-H3R heteromers via 1R. To test this, we analyzed the effect
of H3R ligands on the D1R agonist SKF 38393-induced cell death
in organotypic cultures pretreated with 1R agonists and antag-
onists. The pretreatment with the agonist PRE-084 (1 M) mim-
icked the effect of cocaine in the H3R ligand modulation of
D1R-induced cell death (Fig. 9a) and the pretreatment with the
antagonist PD 144418 (10 M), which had no effect in this pro-
cess (Fig. 9b), could block the 150 M cocaine’s effects on the
D1R-H3R heteromer in our cell death model (Fig. 9c). We also
analyzed theD1R-H3R cross-talk and cross-antagonism in signal-
ing in rat striatal slices pretreated with 1 M PRE-084 or 10 M
PD 144418 in the absence or in the presence of 150 M cocaine.
Figure 9. Effect of1R agonist and antagonists on the H3R-mediatedmodulation of the D1R-promoted cell death and signaling in the striatum. Rat striatal organotypic cultures (a– c) or striatal
slices (d–f ) were prepared as indicated (seeMaterials andMethods) andwere treated for 1 hwithmedium (a, d) or PD 144418 (10M; b, c, e, f ) before adding 1M PRE-084 (a, d), vehicle (b, e),
or 150M cocaine (c, f ). At 24 h of organotypic culture (a– c) or after 2 h of slice incubation (d–f ) the D1R antagonist SCH 23390 (50M, a– c or 10M, d–f ) or the H3R antagonist thioperamide
(10M) were added 20 min before the addition of the D1R agonist SKF 38393 (50M, a– c or 1M, d–f ) or the H3R agonist imetit (10M, a– c or 1M, d–f ) alone or in combination. Striatal
organotypic cultureswere cultured for an additional 48 h and sliceswere incubated for an additional 10min andwere processed to determine cell death or ERK 1/2 phosphorylation, respectively, as
indicated inMaterials andMethods. a– c, Values representmean SEMpercentage of PI stained cells versus total DAPI-stained cells determined in four to six fields from two to three independent
organotypic cultures. d–f, Values representmean SEM phosphorylation relative to basal levels found in untreated slices, determined in 3–10 slices obtained from four animals. One-way ANOVA
followed by Bonferroni post hoc tests showed a significant (*p 0.05, ***p 0.001) effect over basal (nontreated organotypic cultures or slices) or of the two ligands treatment over the agonist
treatment ( #p 0.05, ###p 0.001).
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As shown in Figure 9d, PRE-084 mim-
icked cocaine’s effect by blocking the neg-
ative cross-talk between SKF 38393 and
imetit in ERK 1/2 phosphorylation and the
cross-antagonism between both receptors.
When striatal slices where pretreated with the
1 receptor antagonist PD 144418 (10 M)
cocaine could no longer block H3 receptor’s
control of D1 receptor signaling (Fig. 9f). PD
144418 had no effect in theH3R ligandmod-
ulation of D1R signaling (Fig. 9e) suggesting
that itwas indeed throughblockageofcocaine
binding. These data strongly suggest thatH3R
controlofD1Rsignalingcanbepharmacolog-
ically influenced with 1R compounds and
that1Rantagonistsmayproveeffective at re-
ducing the effects of cocaine.
Discussion
From the data presented here four major
conclusions can be made. First, 1R binds
D1R-H3R heteromers in transfected cells
as well as in mouse and rat striatum. Sec-
ond, 1R agonists, such as cocaine, mod-
ify the structure and counteract the
biochemical properties of the D1R-H3R
heteromer, composing of heteromer sig-
naling through Gi protein, the ability of
H3R activation to signal through MAPK,
and the ability of H3R ligands to inhibit
the effects of D1R-mediated signaling, in-
cluding cell death. Therefore, a third im-
portant general conclusion is that
blockade of H3R-mediated inhibition of
D1R function in the 1R-D1R-H3R com-
plexes plays a key role in the effects of co-
caine. Finally, 1R-D1R-H3R complexes might provide a new
target for the treatment of cocaine abuse.
Cocaine binds with somewhat higher affinity to DAT than to
1R; therefore, the role of 1R in the addictive properties of co-
caine has been a matter of debate. More accepted has been their
role in the acute neurotoxic effects of cocaine (for review, see
Robson et al., 2012). In fact, 1R antagonists provide a protective
effect in cocaine-induced convulsions and lethality in rodents
(Ritz and George, 1997; Robson et al., 2012). Nevertheless, an
important amount of experimental data demonstrates the in-
volvement of 1R in many pharmacologic, including rewarding,
effects of cocaine (Maurice and Su, 2009; Robson et al., 2012).
Repeated cocaine exposure increases the levels of 1R in the
brain, including the striatum, by a process that depends on the
cocaine binding 1R (Liu and Matsumoto, 2008), and does not
occur in mice with genetic deletion of D1R (Zhang et al., 2005).
Upregulation of 1R might underlie the ability of cocaine to in-
duce self-administration of selective 1R agonists, which has
been invoked as a possible mechanism that contributes to the
intractability of psychostimulant abuse (Hiranita et al., 2013).
Indeed, we have demonstrated the importance of the 1R and
D1R receptor interaction on the initial events upon cocaine ex-
posure (Navarro et al., 2010).
We previously described that in the striatum D1R can form
heteromers with H3R and that H3R agonist binding to the D1R-
H3R heteromers are negatively modulating D1R function (Fer-
rada et al., 2009; Moreno et al., 2011a). The modulation of D1R
signaling by H3R is thought to serve as a control point that could
set the tone of D1R signaling from a given neuron (Moreno et al.,
2011a; Ellenbroek, 2013; Panula and Nuutinen, 2013). However,
previous studies using the H3R ligand imetit have shown that it
was not effective at preventing drug seeking in the presence of
cocaine, but does prevent drug seeking in the absence of cocaine
(Ortiz De Pablo and Self, 2011). Our work here clearly explains
themolecular mechanism behind these results and highlights the
pleiotropic effects of 1R. As stated in Figure 10, H3R and D1R
form heteromers to which 1R can bind. Under normal condi-
tions (in the absence of cocaine), H3R can serve to control the
levels of D1R signaling altering its coupling to G-proteins. Acti-
vating only the D1R protomer in the heteromer promotes a de-
crease of cAMP levels in accordance with Gi coupling to the
heteromer. In addition, D1R activation induces -arrestin re-
cruitment and promotes ERK 1/2 phosphorylation (Fig. 10a).
However, upon dual stimulation of the heteromer with bothH3R
and D1R agonists in the absence of cocaine, a negative cross-talk
between receptors in the heteromer occurs, inhibiting -arrestin
recruitment and subsequently reducing ERK 1/2 phosphoryla-
tion from the heteromer (Fig. 10b). When cocaine (Fig. 10c)
binds to 1R in the heteromeric complex, it induces structural
changes in the heteromer, and disrupts the negative cross-talk.
Thus, in the presence of cocaine the H3R-mediated brake onD1R
is lost. Importantly, cocaine also blocks the dopamine trans-
porter, DAT, in presynaptic terminals. This leads to an increase in
extracellular levels of dopamine. This dopamine then can bind
Figure 10. Scheme representing the D1R signaling in the D1R-H3R heteromer in the absence or presence of cocaine. In GABAe-
rgic neurons (gray), in the absenceof cocaine,H3R (blue) andD1R (red) formheteromers towhich1R (yellow) canbind. Activation
of only the D1R protomer (a) promotes a decrease of cAMP levels in accordance with Gi (orange) coupling of both receptors in the
heteromer. Moreover, D1R activation induces-arrestin (purple) recruitment and promotes ERK 1/2 phosphorylation. Upon dual
stimulation of the heteromerwith both H3R andD1R agonists in the absence of cocaine (b), a negative cross-talk (the ability of one
receptor agonist to negatively modulate the partner receptor ligand binding or signaling) between receptors in the heteromer
occurs, inhibiting-arrestin recruitment and subsequently reducing ERK 1/2 phosphorylation from the heteromer.When cocaine
(brown) binds to 1R (c) this induces structural changes in the heteromer disrupting the negative cross-talk. Thus, the H3R-
mediated brake on D1R is lost, allowing D1R (green) to couple to Gs (pale green) and increasing cAMP. Importantly, -arrestin
recruitment and ERK 1/2 phosphorylation are also detected in the presence of cocaine.
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and activate an uninhibited D1R allowing D1R to increase cAMP
by coupling to Gs protein and increasing p-ERK 1/2, presumably
via recruitment of -arrestin. This uninhibited D1R is normally
balanced by inputs from D2R-containing neurons. However, we
and others have shown that this balance becomes undone in the
presence of cocaine (Navarro et al., 2013; Park et al., 2013).
The present study supports the use of 1R antagonists as a
treatment for cocaine abuse, particularly in the frame of 1R
modulation of D1R-H3R heteromers. In fact, we showed that
blockade of 1R restores the protective H3R-mediated brake on
D1R signaling involved in cocaine-induced cell death. Although
at the experimental level D1R seems to be clearly involved in the
pharmacological effects of cocaine (Xu et al., 1994; Weiss et al.,
2001;Wolf et al., 2003; Bertran-Gonzalez et al., 2008), conflicting
results of D1R antagonists have been observed at the clinical level
(Nann-Vernotica et al., 2001), which might be related to the in-
ability to reach therapeutic doses without secondary effects. An-
tagonists of1R receptors can block cocaine’s ability tomodulate
D1-H3 receptor heteromers, providing a means to decrease the
overdose-related side effects of orthosteric D1 receptor antago-
nists. Our results indicate that a potentially good therapeutic
approach for the pharmacologic effects of cocaine could include
the association of 1R antagonists with H3 receptor agonists.
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